Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-041720
Filing Date
2010-08-09
Accepted
2010-08-09 16:06:27
Documents
1
Period of Report
2010-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9243
  Complete submission text file 0001209191-10-041720.txt   10879
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Issuer) CIK: 0001008848 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACORDA THERAPEUTICS, INC. 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
COHEN RON (Reporting) CIK: 0001272354 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50513 | Film No.: 101001675